# QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects

> **NCT05650528** · PHASE1 · COMPLETED · sponsor: **Amckaus PTY LTD.** · enrollment: 78 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** QG101-23-0 capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05650528
- **Lead sponsor:** Amckaus PTY LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-21
- **Primary completion:** 2024-01-24
- **Final completion:** 2024-02-26
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05650528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05650528, "QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05650528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*